1-8 of 8
Jyotsna Kapoor
Close
Sort by
Journal Articles

An Observational Prospective Study of Dasatinib 50mg Daily As Frontline Therapy in Newly Diagnosed Chronic Myeloid Leukemia Patients in Chronic Phase

Reema Singh, Rohan Halder, Jyotsna Kapoor, Megha Verma, Pallavi Mehta, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani
Journal: Blood
Blood (2022) 140 (Supplement 1): 12197–12199.
https://doi.org/10.1182/blood-2022-158453
Published: 2022
Journal Articles

Combination of Venetoclax and Hypomethylating Agents in Myeloid Malignancies in Patients Unfit for Intensive Chemotherapy - Real World Data from a Tertiary Care Centre in India. Is It Time to Bid Adieu to 3+7?

Sumeet Prakash Mirgh, MBBS, MDDM, Jyotsna Kapoor, MSc, Shinto Francis Thekuddan, MD DM, Vishvdeep Khushoo, MBBS, MDDM, Faran Naim, MD DNB, Ambar Garg, MD DNB, Narendra Agrawal, MD DM, Rayaz Ahmed, MDDM, Dinesh Bhurani, MD DM, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5149.
https://doi.org/10.1182/blood-2019-131746
Published: 2019
Journal Articles

Experience with Low Dose Thalidomide in Transfusion Dependent Beta Thalassaemia in a Resource Limited Setting

Pallavi Mehta, MD DM, Neha Yadav, BDS , MBA, Priyanka Soni, MD FNB, Shinto Francis Thekuddan, MBBS,MDDM, Reema Singh, MSc, Vishvdeep Khushoo, MBBS,MDDM, Sumeet Prakash Mirgh, MBBS,MDDM, Narendra Agrawal, MD DM, Rayaz Ahmed, MDDM, Jyotsna Kapoor, MSc, Dinesh Bhurani, MD DM, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 963.
https://doi.org/10.1182/blood-2019-131682
Published: 2019
Journal Articles

Ibrutinib Monotherapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma: A Retrospective Single Center Experience from India

Rayaz Ahmed, MDDM, Dinesh Bhurani, MD DM, FRCPA, Narendra Agarwal, MD DM, Jyotsna Kapoor, MSc, Neha Gurha, MD, Manan Shah, MBBS, MHA, Prashant Narang, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5561.
https://doi.org/10.1182/blood-2018-99-112348
Published: 2018
Journal Articles

Incidence of Breakthrough Invasive Fungal Infections after Posaconazole Prophylaxis in Allogeneic Stem Cell Transplant Patients

Rayaz Ahmed, MD DM, Sanghmitra Thakur, MSc, Jyotsna Kapoor, MSc, Narendra Agrawal, MD DM, Pallavi Mehta, MD DM, Shinto Francis Thekuddan, MD DM, Ambar Garg, MD, Dinesh Bhurani, MD DM, FRCPA
Journal: Blood
Blood (2018) 132 (Supplement 1): 5695.
https://doi.org/10.1182/blood-2018-99-118157
Published: 2018
Journal Articles

Primary Plasma Cell Leukemia: Clinical Profile and Treatment Outcomes of a Rare Disease from Tertiary Cancer Centre from India

Mukul Aggarwal, DM, Neha Yadav, BDS , MBA, Jyotsna Kapoor, MSc, Rayaz Ahmed, MDDM, Narendra Agrawal, MD DM, Priyanka Verma, MD, Pragya Bhandari, MD, Dinesh Bhurani, MD DM, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 5400.
https://doi.org/10.1182/blood.V130.Suppl_1.5400.5400
Published: 2017
Journal Articles

Outcome of BCR-ABL/Philadelphia Positive Acute Lymphoblastic Leukemia: A Single Centre Experience from Developing Country

Narendra Agrawal, MD DM, Priyanka Verma, MD, Neha Yadav, BDS , MBA, Rayaz Ahmed, MDDM, Mukul Aggarwal, DM, Pragya Bhandari, MD, Niharika Bhatia, MSc, Jyotsna Kapoor, MSc, Dinesh Bhurani, MD DM, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 5006.
https://doi.org/10.1182/blood.V130.Suppl_1.5006.5006
Published: 2017
Journal Articles

Presence of GvHD and Fever of Unknown Origin Could be a Tubercular Infection Post Allogenic Hematopoietic Stem Cell Transplant

Narendra Agrawal, MD DM, Mukul Aggarwal, DM, MD, Jyotsna Kapoor, MSc, Niharika Bhatia, MSc, Rayaz Ahmed, MDDM, Dinesh Bhurani, MD, DM , FRCPA
Journal: Blood
Blood (2016) 128 (22): 5864.
https://doi.org/10.1182/blood.V128.22.5864.5864
Published: 2016